Modeling of Hydrogen Absorption/Desorption in a Metal Hydride Bed Reactor — A Theoretical Study
Hydrogen has been considered as an alternative source of fuel to the fossil fuel in future, most especially, for mobile applications. However, a requirement is the safe, efficient and compact onboard storage of hydrogen. Reversible storage in metal hydride is promising, but adequate knowledge of materials system fulfills all requirements regarding hydrogen content is a major drawback, release temperature, and reversibility simultaneously. Hydrogen absorptiondesorption in a metal hydride bed reactor can be modeled using different software such as FLUENT, CFDACE, and COMSOL Multiphysics. This book chapter will focus on the use of software COMSOL Multiphysics to simulate the diffusion and heating of hydrogen and metal hydride powder in both radial and axial directions. The model consists of system of partial differential equations (PDE) describing two-dimensional heat and mass transfer of hydrogen in a porous matrix. The influence of the operating parameters Temperature, Pressure, Concentration, Permeability and Thermal Conductivity on the rate of absorption-desorption of hydrogen in metal hydride will be fully discussed. The simulation results obtained could be applied to the on board hydrogen storage technology, in particular for the hydrogen supply of a fuel cell for powering of a hydrogen fuel cell vehicle.
A three-dimensional mathematical model for absorption in a metal hydride bed
Heat and mass transfer, fluid flow and chemical reactions in a hydride bed are numerically investigated with a general purpose PHOENICS code. Hydride formation takes place faster near the cooled boundary walls and slower around the core region of the bed. It is found that fluid flow affects the temperature distribution in the system, however, it does not significantly improve the amount of hydrogen absorbed.
The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats
We evaluated if the brain bradykinin (BK) B1 receptor is involved in the regulation of blood pressure (BP) in conscious rats. Basal mean BP and HR were 115±2 and 165±3 mmHg and 345±10 and 410±14 beats min−1 in Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR), respectively. Intracerebroventricular (i.c.v.) injection of 1 nmol B1 receptor agonist Lys‐desArg9‐BK significantly increased the BP of WKY and SHR by 7±1 and 19±2 mmHg, respectively. One nmol Sar[D‐Phe8]‐desArg9‐BK, a kininase‐resistant B1 agonist, increased the BP of WKY and SHR by 19±2 and 17±2 mmHg, respectively and reduced HR in both strains. I.c.v. injection of 0.01 nmol B1 antagonists, LysLeu8‐desArg9‐BK or AcLys[D‐βNal7,Ile8]‐desArg9‐BK (R715), significantly decreased mean BP in SHR (by 9±2 mmHg the former and 14±3 mmHg the latter compound), but not in WKY. In SHR, the BP response to R715 was associated to tachycardia. I.c.v. Captopril, a kininase inhibitor, increased the BP of SHR, this response being partially prevented by i.c.v. R715 and reversed into a vasodepressor effect by R715 in combination with the B2 antagonist Icatibant. I.c.v. antisense oligodeoxynucleotides (ODNs) targeted to the B1 receptor mRNA decreased BP in SHR, but not in WKY. HR was not altered in either strain. Distribution of fluorescein‐conjugated ODNs was detected in brain areas surrounding cerebral ventricles. Our results indicate that the brain B1 receptor participates in the regulation of BP. Activation of the B1 receptor by kinin metabolites could participate in the pathogenesis of hypertension in SHR.